Paolo Rizzardi

Paolo Rizzardi is the Co-Founder, Chairman & CEO of Altheia Science, an innovative clinical-ready SME focusing on developing therapeutic strategies for diseases with high unmet needs. Paolo is also the Co-Founder and Managing Partner of AurorA-TT, which aims to translate breakthrough discoveries into therapies. Previously, Paolo served as the General Manager at MolMed and held various medical positions at renowned institutions in Italy, Switzerland, and the UK. Paolo Rizzardi holds degrees in Internal Medicine and Medicine&Surgery from Università degli Studi di Milano with additional education from Tufts University.